nodes	percent_of_prediction	percent_of_DWPC	metapath
Chlorphenamine—Drug eruption—Spironolactone—dilated cardiomyopathy	0.0652	0.0725	CcSEcCtD
Chlorphenamine—Cerebration impaired—Furosemide—dilated cardiomyopathy	0.0371	0.0413	CcSEcCtD
Chlorphenamine—Drug eruption—Furosemide—dilated cardiomyopathy	0.0355	0.0395	CcSEcCtD
Chlorphenamine—Disturbance in attention—Furosemide—dilated cardiomyopathy	0.0252	0.028	CcSEcCtD
Chlorphenamine—Drowsiness—Spironolactone—dilated cardiomyopathy	0.0224	0.025	CcSEcCtD
Chlorphenamine—Agranulocytosis—Spironolactone—dilated cardiomyopathy	0.0209	0.0233	CcSEcCtD
Chlorphenamine—Mental disability—Furosemide—dilated cardiomyopathy	0.0189	0.0211	CcSEcCtD
Chlorphenamine—Chest discomfort—Lisinopril—dilated cardiomyopathy	0.0185	0.0206	CcSEcCtD
Chlorphenamine—Photosensitivity—Furosemide—dilated cardiomyopathy	0.018	0.0201	CcSEcCtD
Chlorphenamine—Haemolytic anaemia—Furosemide—dilated cardiomyopathy	0.0175	0.0195	CcSEcCtD
Chlorphenamine—Mepyramine—SLC22A5—dilated cardiomyopathy	0.0161	0.509	CrCbGaD
Chlorphenamine—Wheezing—Lisinopril—dilated cardiomyopathy	0.0159	0.0177	CcSEcCtD
Chlorphenamine—Irritability—Furosemide—dilated cardiomyopathy	0.0151	0.0168	CcSEcCtD
Chlorphenamine—Urinary retention—Furosemide—dilated cardiomyopathy	0.0151	0.0168	CcSEcCtD
Chlorphenamine—Confusional state—Spironolactone—dilated cardiomyopathy	0.0144	0.016	CcSEcCtD
Chlorphenamine—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.014	0.0156	CcSEcCtD
Chlorphenamine—Photosensitivity—Lisinopril—dilated cardiomyopathy	0.0135	0.0151	CcSEcCtD
Chlorphenamine—Haemolytic anaemia—Lisinopril—dilated cardiomyopathy	0.0132	0.0146	CcSEcCtD
Chlorphenamine—Nasal congestion—Lisinopril—dilated cardiomyopathy	0.013	0.0145	CcSEcCtD
Chlorphenamine—Somnolence—Spironolactone—dilated cardiomyopathy	0.0127	0.0141	CcSEcCtD
Chlorphenamine—Pollakiuria—Furosemide—dilated cardiomyopathy	0.0126	0.0141	CcSEcCtD
Chlorphenamine—Photosensitivity reaction—Furosemide—dilated cardiomyopathy	0.0125	0.0139	CcSEcCtD
Chlorphenamine—Drowsiness—Furosemide—dilated cardiomyopathy	0.0122	0.0136	CcSEcCtD
Chlorphenamine—Diplopia—Lisinopril—dilated cardiomyopathy	0.0119	0.0132	CcSEcCtD
Chlorphenamine—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.0118	0.0131	CcSEcCtD
Chlorphenamine—Agranulocytosis—Furosemide—dilated cardiomyopathy	0.0114	0.0127	CcSEcCtD
Chlorphenamine—Irritability—Lisinopril—dilated cardiomyopathy	0.0113	0.0126	CcSEcCtD
Chlorphenamine—Tinnitus—Furosemide—dilated cardiomyopathy	0.0102	0.0114	CcSEcCtD
Chlorphenamine—Sweating increased—Lisinopril—dilated cardiomyopathy	0.01	0.0111	CcSEcCtD
Chlorphenamine—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.00979	0.0109	CcSEcCtD
Chlorphenamine—Orphenadrine—SCN5A—dilated cardiomyopathy	0.00966	0.305	CrCbGaD
Chlorphenamine—Dizziness—Spironolactone—dilated cardiomyopathy	0.00946	0.0105	CcSEcCtD
Chlorphenamine—Photosensitivity reaction—Lisinopril—dilated cardiomyopathy	0.00938	0.0104	CcSEcCtD
Chlorphenamine—Vomiting—Spironolactone—dilated cardiomyopathy	0.0091	0.0101	CcSEcCtD
Chlorphenamine—Vision blurred—Furosemide—dilated cardiomyopathy	0.00899	0.01	CcSEcCtD
Chlorphenamine—Neuropathy peripheral—Lisinopril—dilated cardiomyopathy	0.00898	0.00999	CcSEcCtD
Chlorphenamine—Headache—Spironolactone—dilated cardiomyopathy	0.00896	0.00997	CcSEcCtD
Chlorphenamine—Agitation—Furosemide—dilated cardiomyopathy	0.00877	0.00975	CcSEcCtD
Chlorphenamine—Vertigo—Furosemide—dilated cardiomyopathy	0.00857	0.00953	CcSEcCtD
Chlorphenamine—Agranulocytosis—Lisinopril—dilated cardiomyopathy	0.00855	0.00951	CcSEcCtD
Chlorphenamine—Nausea—Spironolactone—dilated cardiomyopathy	0.0085	0.00945	CcSEcCtD
Chlorphenamine—SLC22A2—Organic cation transport—SLC22A5—dilated cardiomyopathy	0.00848	0.122	CbGpPWpGaD
Chlorphenamine—Hallucination—Lisinopril—dilated cardiomyopathy	0.00818	0.0091	CcSEcCtD
Chlorphenamine—Dry mouth—Furosemide—dilated cardiomyopathy	0.00794	0.00883	CcSEcCtD
Chlorphenamine—SLC22A1—Organic cation transport—SLC22A5—dilated cardiomyopathy	0.0079	0.114	CbGpPWpGaD
Chlorphenamine—Confusional state—Furosemide—dilated cardiomyopathy	0.00785	0.00873	CcSEcCtD
Chlorphenamine—Tinnitus—Lisinopril—dilated cardiomyopathy	0.00767	0.00853	CcSEcCtD
Chlorphenamine—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.00762	0.00848	CcSEcCtD
Chlorphenamine—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.00753	0.00837	CcSEcCtD
Chlorphenamine—Anorexia—Furosemide—dilated cardiomyopathy	0.00742	0.00825	CcSEcCtD
Chlorphenamine—Chills—Lisinopril—dilated cardiomyopathy	0.00738	0.00821	CcSEcCtD
Chlorphenamine—Hypotension—Furosemide—dilated cardiomyopathy	0.00727	0.00809	CcSEcCtD
Chlorphenamine—Tension—Lisinopril—dilated cardiomyopathy	0.00702	0.00781	CcSEcCtD
Chlorphenamine—Paraesthesia—Furosemide—dilated cardiomyopathy	0.00699	0.00778	CcSEcCtD
Chlorphenamine—Nervousness—Lisinopril—dilated cardiomyopathy	0.00695	0.00773	CcSEcCtD
Chlorphenamine—Somnolence—Furosemide—dilated cardiomyopathy	0.00692	0.0077	CcSEcCtD
Chlorphenamine—Decreased appetite—Furosemide—dilated cardiomyopathy	0.00677	0.00753	CcSEcCtD
Chlorphenamine—Vision blurred—Lisinopril—dilated cardiomyopathy	0.00675	0.0075	CcSEcCtD
Chlorphenamine—Fatigue—Furosemide—dilated cardiomyopathy	0.00671	0.00747	CcSEcCtD
Chlorphenamine—Tremor—Lisinopril—dilated cardiomyopathy	0.00671	0.00746	CcSEcCtD
Chlorphenamine—Constipation—Furosemide—dilated cardiomyopathy	0.00666	0.0074	CcSEcCtD
Chlorphenamine—Vertigo—Lisinopril—dilated cardiomyopathy	0.00643	0.00715	CcSEcCtD
Chlorphenamine—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.00642	0.00714	CcSEcCtD
Chlorphenamine—Palpitations—Lisinopril—dilated cardiomyopathy	0.00632	0.00703	CcSEcCtD
Chlorphenamine—Anxiety—Lisinopril—dilated cardiomyopathy	0.00607	0.00675	CcSEcCtD
Chlorphenamine—Dry mouth—Lisinopril—dilated cardiomyopathy	0.00596	0.00663	CcSEcCtD
Chlorphenamine—Confusional state—Lisinopril—dilated cardiomyopathy	0.00589	0.00655	CcSEcCtD
Chlorphenamine—Diphenhydramine—SLC22A5—dilated cardiomyopathy	0.00588	0.186	CrCbGaD
Chlorphenamine—SLC22A2—Organic cation/anion/zwitterion transport—SLC22A5—dilated cardiomyopathy	0.00575	0.083	CbGpPWpGaD
Chlorphenamine—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.00572	0.00636	CcSEcCtD
Chlorphenamine—Tachycardia—Lisinopril—dilated cardiomyopathy	0.0057	0.00634	CcSEcCtD
Chlorphenamine—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.00565	0.00628	CcSEcCtD
Chlorphenamine—Asthenia—Furosemide—dilated cardiomyopathy	0.00559	0.00621	CcSEcCtD
Chlorphenamine—Anorexia—Lisinopril—dilated cardiomyopathy	0.00557	0.00619	CcSEcCtD
Chlorphenamine—Hypotension—Lisinopril—dilated cardiomyopathy	0.00546	0.00607	CcSEcCtD
Chlorphenamine—SLC22A1—Organic cation/anion/zwitterion transport—SLC22A5—dilated cardiomyopathy	0.00536	0.0774	CbGpPWpGaD
Chlorphenamine—Diarrhoea—Furosemide—dilated cardiomyopathy	0.00533	0.00592	CcSEcCtD
Chlorphenamine—Insomnia—Lisinopril—dilated cardiomyopathy	0.00528	0.00588	CcSEcCtD
Chlorphenamine—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.00525	0.00583	CcSEcCtD
Chlorphenamine—Somnolence—Lisinopril—dilated cardiomyopathy	0.00519	0.00578	CcSEcCtD
Chlorphenamine—Dizziness—Furosemide—dilated cardiomyopathy	0.00515	0.00573	CcSEcCtD
Chlorphenamine—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.00514	0.00572	CcSEcCtD
Chlorphenamine—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.00508	0.00565	CcSEcCtD
Chlorphenamine—Fatigue—Lisinopril—dilated cardiomyopathy	0.00504	0.0056	CcSEcCtD
Chlorphenamine—Constipation—Lisinopril—dilated cardiomyopathy	0.005	0.00556	CcSEcCtD
Chlorphenamine—Vomiting—Furosemide—dilated cardiomyopathy	0.00495	0.00551	CcSEcCtD
Chlorphenamine—Headache—Furosemide—dilated cardiomyopathy	0.00488	0.00542	CcSEcCtD
Chlorphenamine—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.00481	0.00535	CcSEcCtD
Chlorphenamine—Nausea—Furosemide—dilated cardiomyopathy	0.00462	0.00514	CcSEcCtD
Chlorphenamine—Asthenia—Lisinopril—dilated cardiomyopathy	0.00419	0.00466	CcSEcCtD
Chlorphenamine—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.004	0.00445	CcSEcCtD
Chlorphenamine—Dizziness—Lisinopril—dilated cardiomyopathy	0.00386	0.0043	CcSEcCtD
Chlorphenamine—Vomiting—Lisinopril—dilated cardiomyopathy	0.00371	0.00413	CcSEcCtD
Chlorphenamine—Headache—Lisinopril—dilated cardiomyopathy	0.00366	0.00407	CcSEcCtD
Chlorphenamine—Nausea—Lisinopril—dilated cardiomyopathy	0.00347	0.00386	CcSEcCtD
Chlorphenamine—SLC6A4—Circadian rythm related genes—SIK1—dilated cardiomyopathy	0.00177	0.0255	CbGpPWpGaD
Chlorphenamine—SLC6A4—SIDS Susceptibility Pathways—SCN5A—dilated cardiomyopathy	0.00164	0.0237	CbGpPWpGaD
Chlorphenamine—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—dilated cardiomyopathy	0.00143	0.0206	CbGpPWpGaD
Chlorphenamine—SLC6A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—dilated cardiomyopathy	0.00127	0.0183	CbGpPWpGaD
Chlorphenamine—SLC6A4—Monoamine Transport—AGT—dilated cardiomyopathy	0.00118	0.017	CbGpPWpGaD
Chlorphenamine—SLC6A4—SIDS Susceptibility Pathways—RYR2—dilated cardiomyopathy	0.00117	0.0169	CbGpPWpGaD
Chlorphenamine—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—dilated cardiomyopathy	0.00115	0.0166	CbGpPWpGaD
Chlorphenamine—HRH1—Monoamine GPCRs—ADRB1—dilated cardiomyopathy	0.00115	0.0166	CbGpPWpGaD
Chlorphenamine—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—dilated cardiomyopathy	0.00107	0.0155	CbGpPWpGaD
Chlorphenamine—SLC6A2—Monoamine Transport—AGT—dilated cardiomyopathy	0.00101	0.0146	CbGpPWpGaD
Chlorphenamine—HRH1—Amine ligand-binding receptors—ADRB1—dilated cardiomyopathy	0.000966	0.014	CbGpPWpGaD
Chlorphenamine—HRH1—Monoamine GPCRs—ADRB2—dilated cardiomyopathy	0.000932	0.0135	CbGpPWpGaD
Chlorphenamine—SLC6A3—Monoamine Transport—AGT—dilated cardiomyopathy	0.000898	0.013	CbGpPWpGaD
Chlorphenamine—HRH1—Amine ligand-binding receptors—ADRB2—dilated cardiomyopathy	0.000783	0.0113	CbGpPWpGaD
Chlorphenamine—CYP2D6—Melatonin metabolism and effects—ADRB1—dilated cardiomyopathy	0.000757	0.0109	CbGpPWpGaD
Chlorphenamine—SLC6A2—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.000649	0.00938	CbGpPWpGaD
Chlorphenamine—SLC6A3—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.000632	0.00913	CbGpPWpGaD
Chlorphenamine—HRH1—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.000587	0.00847	CbGpPWpGaD
Chlorphenamine—SLC22A2—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.000575	0.00831	CbGpPWpGaD
Chlorphenamine—SLC6A3—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.000575	0.00831	CbGpPWpGaD
Chlorphenamine—HRH1—IL-4 Signaling Pathway—RPS6KB1—dilated cardiomyopathy	0.00054	0.0078	CbGpPWpGaD
Chlorphenamine—SLC22A1—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.000536	0.00775	CbGpPWpGaD
Chlorphenamine—SLC6A4—Monoamine Transport—TNF—dilated cardiomyopathy	0.000534	0.00772	CbGpPWpGaD
Chlorphenamine—SLC22A2—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.000523	0.00756	CbGpPWpGaD
Chlorphenamine—SLC6A3—Neuronal System—ABCC9—dilated cardiomyopathy	0.000505	0.0073	CbGpPWpGaD
Chlorphenamine—SLC22A1—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.000488	0.00705	CbGpPWpGaD
Chlorphenamine—SLC6A3—Neuronal System—ACTN2—dilated cardiomyopathy	0.000485	0.007	CbGpPWpGaD
Chlorphenamine—SLC22A2—Neuronal System—ABCC9—dilated cardiomyopathy	0.00046	0.00664	CbGpPWpGaD
Chlorphenamine—SLC6A2—Monoamine Transport—TNF—dilated cardiomyopathy	0.00046	0.00664	CbGpPWpGaD
Chlorphenamine—SLC6A4—SIDS Susceptibility Pathways—GJA1—dilated cardiomyopathy	0.000456	0.00659	CbGpPWpGaD
Chlorphenamine—SLC22A2—Neuronal System—ACTN2—dilated cardiomyopathy	0.000441	0.00637	CbGpPWpGaD
Chlorphenamine—SLC22A1—Neuronal System—ABCC9—dilated cardiomyopathy	0.000429	0.00619	CbGpPWpGaD
Chlorphenamine—SLC22A1—Neuronal System—ACTN2—dilated cardiomyopathy	0.000411	0.00594	CbGpPWpGaD
Chlorphenamine—SLC6A3—Monoamine Transport—TNF—dilated cardiomyopathy	0.000407	0.00588	CbGpPWpGaD
Chlorphenamine—SLC6A4—SIDS Susceptibility Pathways—IL10—dilated cardiomyopathy	0.000395	0.00571	CbGpPWpGaD
Chlorphenamine—SLC6A2—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000339	0.0049	CbGpPWpGaD
Chlorphenamine—SLC6A2—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.00033	0.00477	CbGpPWpGaD
Chlorphenamine—SLC6A2—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.00033	0.00477	CbGpPWpGaD
Chlorphenamine—SLC6A2—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000307	0.00443	CbGpPWpGaD
Chlorphenamine—SLC6A3—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.0003	0.00434	CbGpPWpGaD
Chlorphenamine—SLC6A3—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000292	0.00422	CbGpPWpGaD
Chlorphenamine—SLC6A3—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000292	0.00422	CbGpPWpGaD
Chlorphenamine—SLC6A4—Circadian rythm related genes—FAS—dilated cardiomyopathy	0.000289	0.00418	CbGpPWpGaD
Chlorphenamine—SLC22A2—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000273	0.00395	CbGpPWpGaD
Chlorphenamine—SLC6A3—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000272	0.00392	CbGpPWpGaD
Chlorphenamine—SLC22A2—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000266	0.00384	CbGpPWpGaD
Chlorphenamine—SLC22A2—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000266	0.00384	CbGpPWpGaD
Chlorphenamine—SLC22A1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000255	0.00368	CbGpPWpGaD
Chlorphenamine—SLC22A1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000248	0.00358	CbGpPWpGaD
Chlorphenamine—SLC22A1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000248	0.00358	CbGpPWpGaD
Chlorphenamine—SLC22A2—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000247	0.00357	CbGpPWpGaD
Chlorphenamine—HRH1—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.000246	0.00356	CbGpPWpGaD
Chlorphenamine—HRH1—G alpha (q) signalling events—AGTR1—dilated cardiomyopathy	0.000245	0.00354	CbGpPWpGaD
Chlorphenamine—SLC22A1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.00023	0.00333	CbGpPWpGaD
Chlorphenamine—HRH1—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.000229	0.00331	CbGpPWpGaD
Chlorphenamine—HRH1—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.000222	0.0032	CbGpPWpGaD
Chlorphenamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—AGTR1—dilated cardiomyopathy	0.000219	0.00317	CbGpPWpGaD
Chlorphenamine—HRH1—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.000211	0.00305	CbGpPWpGaD
Chlorphenamine—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.000211	0.00305	CbGpPWpGaD
Chlorphenamine—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.000196	0.00283	CbGpPWpGaD
Chlorphenamine—HRH1—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.00019	0.00275	CbGpPWpGaD
Chlorphenamine—HRH1—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.000189	0.00274	CbGpPWpGaD
Chlorphenamine—CYP3A7—Metabolism—ANKRD1—dilated cardiomyopathy	0.00018	0.0026	CbGpPWpGaD
Chlorphenamine—HRH1—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.00018	0.0026	CbGpPWpGaD
Chlorphenamine—SLC22A2—Metabolism—ANKRD1—dilated cardiomyopathy	0.00018	0.0026	CbGpPWpGaD
Chlorphenamine—HRH1—G alpha (q) signalling events—AGT—dilated cardiomyopathy	0.000173	0.00249	CbGpPWpGaD
Chlorphenamine—CYP3A7—Metabolism—TAZ—dilated cardiomyopathy	0.000169	0.00244	CbGpPWpGaD
Chlorphenamine—SLC22A2—Metabolism—TAZ—dilated cardiomyopathy	0.000169	0.00244	CbGpPWpGaD
Chlorphenamine—SLC22A1—Metabolism—ANKRD1—dilated cardiomyopathy	0.000168	0.00242	CbGpPWpGaD
Chlorphenamine—HRH1—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.000162	0.00234	CbGpPWpGaD
Chlorphenamine—HRH1—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.000161	0.00232	CbGpPWpGaD
Chlorphenamine—HRH1—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.000161	0.00232	CbGpPWpGaD
Chlorphenamine—SLC22A1—Metabolism—TAZ—dilated cardiomyopathy	0.000157	0.00227	CbGpPWpGaD
Chlorphenamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—dilated cardiomyopathy	0.000154	0.00223	CbGpPWpGaD
Chlorphenamine—HRH1—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.000154	0.00222	CbGpPWpGaD
Chlorphenamine—CYP3A7—Metabolism—SDHA—dilated cardiomyopathy	0.000153	0.00221	CbGpPWpGaD
Chlorphenamine—SLC22A2—Metabolism—SDHA—dilated cardiomyopathy	0.000153	0.00221	CbGpPWpGaD
Chlorphenamine—SLC6A4—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	0.00015	0.00217	CbGpPWpGaD
Chlorphenamine—HRH1—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.000149	0.00216	CbGpPWpGaD
Chlorphenamine—HRH1—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000145	0.00209	CbGpPWpGaD
Chlorphenamine—SLC6A3—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.000144	0.00208	CbGpPWpGaD
Chlorphenamine—SLC22A1—Metabolism—SDHA—dilated cardiomyopathy	0.000142	0.00206	CbGpPWpGaD
Chlorphenamine—SLC22A2—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.000131	0.00189	CbGpPWpGaD
Chlorphenamine—CYP3A5—Metabolism—ANKRD1—dilated cardiomyopathy	0.00013	0.00188	CbGpPWpGaD
Chlorphenamine—HRH1—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000124	0.00179	CbGpPWpGaD
Chlorphenamine—CYP3A5—Metabolism—TAZ—dilated cardiomyopathy	0.000122	0.00177	CbGpPWpGaD
Chlorphenamine—SLC22A1—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.000122	0.00176	CbGpPWpGaD
Chlorphenamine—HRH1—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000117	0.00169	CbGpPWpGaD
Chlorphenamine—HRH1—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000114	0.00165	CbGpPWpGaD
Chlorphenamine—CYP3A5—Metabolism—SDHA—dilated cardiomyopathy	0.000111	0.0016	CbGpPWpGaD
Chlorphenamine—SLC6A3—Neuronal System—RAF1—dilated cardiomyopathy	0.00011	0.00159	CbGpPWpGaD
Chlorphenamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—dilated cardiomyopathy	0.000107	0.00155	CbGpPWpGaD
Chlorphenamine—SLC22A2—Neuronal System—RAF1—dilated cardiomyopathy	0.0001	0.00145	CbGpPWpGaD
Chlorphenamine—SLC22A1—Neuronal System—RAF1—dilated cardiomyopathy	9.35e-05	0.00135	CbGpPWpGaD
Chlorphenamine—CYP2D6—Metabolism—ANKRD1—dilated cardiomyopathy	9.25e-05	0.00134	CbGpPWpGaD
Chlorphenamine—HRH1—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	9.09e-05	0.00131	CbGpPWpGaD
Chlorphenamine—HRH1—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	9.09e-05	0.00131	CbGpPWpGaD
Chlorphenamine—HRH1—GPCR ligand binding—AGT—dilated cardiomyopathy	8.7e-05	0.00126	CbGpPWpGaD
Chlorphenamine—CYP2D6—Metabolism—TAZ—dilated cardiomyopathy	8.7e-05	0.00126	CbGpPWpGaD
Chlorphenamine—HRH1—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	8.45e-05	0.00122	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling by GPCR—CXCL2—dilated cardiomyopathy	8.25e-05	0.00119	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling by GPCR—AGTR2—dilated cardiomyopathy	8.25e-05	0.00119	CbGpPWpGaD
Chlorphenamine—HRH1—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	8.18e-05	0.00118	CbGpPWpGaD
Chlorphenamine—CYP2D6—Metabolism—SDHA—dilated cardiomyopathy	7.87e-05	0.00114	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling by GPCR—CXCR3—dilated cardiomyopathy	7.67e-05	0.00111	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling by GPCR—ADRB1—dilated cardiomyopathy	7.43e-05	0.00107	CbGpPWpGaD
Chlorphenamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	7.34e-05	0.00106	CbGpPWpGaD
Chlorphenamine—HRH1—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	6.99e-05	0.00101	CbGpPWpGaD
Chlorphenamine—SLC6A2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	6.69e-05	0.000966	CbGpPWpGaD
Chlorphenamine—HRH1—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	6.63e-05	0.000957	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling by GPCR—AGTR1—dilated cardiomyopathy	6.34e-05	0.000916	CbGpPWpGaD
Chlorphenamine—CYP3A4—Metabolism—ANKRD1—dilated cardiomyopathy	6.05e-05	0.000874	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling by GPCR—ADRB2—dilated cardiomyopathy	6.02e-05	0.000869	CbGpPWpGaD
Chlorphenamine—SLC6A3—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	5.93e-05	0.000856	CbGpPWpGaD
Chlorphenamine—CYP3A4—Metabolism—TAZ—dilated cardiomyopathy	5.69e-05	0.000821	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—PSEN2—dilated cardiomyopathy	5.49e-05	0.000793	CbGpPWpGaD
Chlorphenamine—SLC22A2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	5.39e-05	0.000779	CbGpPWpGaD
Chlorphenamine—HRH1—GPCR downstream signaling—RAC1—dilated cardiomyopathy	5.15e-05	0.000743	CbGpPWpGaD
Chlorphenamine—CYP3A4—Metabolism—SDHA—dilated cardiomyopathy	5.14e-05	0.000743	CbGpPWpGaD
Chlorphenamine—SLC22A1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	5.03e-05	0.000726	CbGpPWpGaD
Chlorphenamine—HRH1—GPCR downstream signaling—AGT—dilated cardiomyopathy	4.92e-05	0.00071	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—CXCL2—dilated cardiomyopathy	4.87e-05	0.000704	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—AGTR2—dilated cardiomyopathy	4.87e-05	0.000704	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling by GPCR—RAC1—dilated cardiomyopathy	4.67e-05	0.000675	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—CXCR3—dilated cardiomyopathy	4.53e-05	0.000654	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling by GPCR—AGT—dilated cardiomyopathy	4.46e-05	0.000645	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—ADRB1—dilated cardiomyopathy	4.39e-05	0.000634	CbGpPWpGaD
Chlorphenamine—CYP3A7—Metabolism—GPX1—dilated cardiomyopathy	4.16e-05	0.0006	CbGpPWpGaD
Chlorphenamine—SLC22A2—Metabolism—GPX1—dilated cardiomyopathy	4.15e-05	0.0006	CbGpPWpGaD
Chlorphenamine—CYP3A7—Metabolism—CD36—dilated cardiomyopathy	4.05e-05	0.000585	CbGpPWpGaD
Chlorphenamine—SLC22A2—Metabolism—CD36—dilated cardiomyopathy	4.04e-05	0.000584	CbGpPWpGaD
Chlorphenamine—SLC22A1—Metabolism—GPX1—dilated cardiomyopathy	3.87e-05	0.000559	CbGpPWpGaD
Chlorphenamine—SLC22A1—Metabolism—CD36—dilated cardiomyopathy	3.77e-05	0.000544	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—AGTR1—dilated cardiomyopathy	3.75e-05	0.000541	CbGpPWpGaD
Chlorphenamine—CYP3A7—Metabolism—AGT—dilated cardiomyopathy	3.65e-05	0.000527	CbGpPWpGaD
Chlorphenamine—SLC22A2—Metabolism—AGT—dilated cardiomyopathy	3.64e-05	0.000526	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—ADRB2—dilated cardiomyopathy	3.56e-05	0.000514	CbGpPWpGaD
Chlorphenamine—SLC22A1—Metabolism—AGT—dilated cardiomyopathy	3.39e-05	0.00049	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling by GPCR—RAF1—dilated cardiomyopathy	3.1e-05	0.000447	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	3.06e-05	0.000441	CbGpPWpGaD
Chlorphenamine—CYP3A5—Metabolism—GPX1—dilated cardiomyopathy	3.01e-05	0.000434	CbGpPWpGaD
Chlorphenamine—CYP3A5—Metabolism—CD36—dilated cardiomyopathy	2.93e-05	0.000423	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—RAC1—dilated cardiomyopathy	2.76e-05	0.000399	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—AGT—dilated cardiomyopathy	2.64e-05	0.000381	CbGpPWpGaD
Chlorphenamine—CYP3A5—Metabolism—AGT—dilated cardiomyopathy	2.64e-05	0.000381	CbGpPWpGaD
Chlorphenamine—CYP2D6—Metabolism—GPX1—dilated cardiomyopathy	2.14e-05	0.000309	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling by GPCR—EGFR—dilated cardiomyopathy	2.12e-05	0.000307	CbGpPWpGaD
Chlorphenamine—CYP2D6—Metabolism—CD36—dilated cardiomyopathy	2.08e-05	0.000301	CbGpPWpGaD
Chlorphenamine—CYP2D6—Metabolism—AGT—dilated cardiomyopathy	1.87e-05	0.000271	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—RAF1—dilated cardiomyopathy	1.83e-05	0.000264	CbGpPWpGaD
Chlorphenamine—CYP3A4—Metabolism—GPX1—dilated cardiomyopathy	1.4e-05	0.000202	CbGpPWpGaD
Chlorphenamine—CYP3A4—Metabolism—CD36—dilated cardiomyopathy	1.36e-05	0.000197	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—EGFR—dilated cardiomyopathy	1.26e-05	0.000181	CbGpPWpGaD
Chlorphenamine—CYP3A4—Metabolism—AGT—dilated cardiomyopathy	1.23e-05	0.000177	CbGpPWpGaD
